Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | MANE Veradermics, Incorporated | ABBV AbbVie |
|---|---|---|
| Price | $121.23 +2.9% | $261.59 -0.6% |
| StockIQ Score | 56C Moderate Risk: Medium | 55C Moderate Risk: High |
| Technical | 72B | 70B |
| Fundamental | 58C | 57C |
| Growth | 32F | 34F |
| Fair Value | 50C- | 33F |
| News | 62C+ | 100A+ |
| Quality | — | 42D |
| Risk | 48D+ | 44D |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
Veradermics (MANE) slightly outperforms AbbVie (ABBV) in technical strength with a score of 72 versus 70. AbbVie has a marginally higher growth score (34 vs. 32) and a better valuation score (50 vs. 33), while both share similar investor and fundamental scores. MANE’s overall technical edge may make it stronger in short-term market trends.
